- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Via Surgical Raises $6 Million for Cartidge-based Hernia Repair Device
Feirce Medical Devices reported that Israel’s Via Surgical brought in $6 million to develop its cartridge-based hernia repair device, a feather in the company’s cap more than a year after its product got an FDA green light.
Feirce Medical Devices reported that Israel’s Via Surgical brought in $6 million to develop its cartridge-based hernia repair device, a feather in the company’s cap more than a year after its product got an FDA green light.
According to the report:
Benslie Investment Group led the funding, giving Via Surgical a boost as it looks to expand its reach for its FasTouch Deployable Suture Fixation system. The device includes a reloadable cartridge with lockable sutures that close around the mesh and the tissue, which helps prevent foreign objects from getting in. FasTouch is also lightweight, the company said on its website, and having less material may cut down on adverse responses from the body or chronic pain in patients following a procedure.
Via Surgical CEO Lena Levin commented:
The addition of Benslie Investment Group to our highly experienced team validates the opportunity to advance patient care with the FasTouch Deployable Suture Fixation System. Their investment will greatly support the increasing clinical demand for improved fixation through our development and commercialization efforts in 2016.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.